Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (26)
Andrew D. Clouston & Stefan G. Hübscher. 2024. MacSween's Pathology of the Liver. MacSween's Pathology of the Liver
947
1038
.
Madhumitha Rabindranath, Rita ZayaKhairunnadiya PrayitnoAni Orchanian-CheffKeyur PatelElmar JaeckelMamatha Bhat. (2023) A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis. Transplantation Direct 9:11, pages e1547.
Crossref
Crossref
Colin Dumont, Nicolas Lanthier & Géraldine Dahlqvist. (2023) Fibrosis and steatosis of the liver graft: Are non-invasive tests useful? A short review. Clinics and Research in Hepatology and Gastroenterology 47:8, pages 102194.
Crossref
Crossref
Lung-Yi Mak, Albert CY Chan, Tiffany CL Wong, Wing-Chiu Dai, Wong-Hoi She, Ka-Wing Ma, Sui-Ling Sin, Ka-Wan Chu, Wai-Kay Seto, Man-Fung Yuen, Chung-Mau Lo & James Fung. (2023) High prevalence of de novo metabolic dysfunction-associated fatty liver disease after liver transplantation and the role of controlled attenuation parameter. BMC Gastroenterology 23:1.
Crossref
Crossref
晓寒 方. (2023) The Utility of CAP and FAST Score in De-Novo NAFLD after Liver Transplantation. Advances in Clinical Medicine 13:04, pages 6976-6985.
Crossref
Crossref
Alshaima Alhinai, Afsheen Qayyum-Khan, Xun Zhang, Patrick Samaha, Peter Metrakos, Marc Deschenes, Philip Wong, Peter Ghali, Tian-Yan Chen & Giada Sebastiani. (2021) Non-alcoholic steatohepatitis in liver transplant recipients diagnosed by serum cytokeratin 18 and transient elastography: A prospective study. World Journal of Hepatology 13:12, pages 2179-2191.
Crossref
Crossref
Ma Ai Thanda Han, Raquel Olivo, Catherine J Choi & Nikolaos Pyrsopoulos. (2021)
De novo
and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
. World Journal of Hepatology 13:12, pages 1991-2004.
Crossref
Crossref
Ivana Mikolasevic, Sanja Stojsavljevic, Filip Blazic, Maja Mijic, Delfa Radic-Kristo, Toni Juric, Nadija Skenderevic, Mia Klapan, Andjela Lukic & Tajana Filipec Kanizaj. (2021) Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?. World Journal of Transplantation 11:3, pages 37-53.
Crossref
Crossref
Javier Tejedor-Tejada, Esteban Fuentes Valenzuela, Rodrigo Nájera Muñoz, Laura Hernandez Gómez, Félix García-Pajares, Carolina Almohalla Álvarez, Fátima Sánchez-Martín, Carmen Alonso-Martín & Gloria Sánchez-Antolín. (2020) De-novo nonalcoholic fatty liver disease at 5 years after liver transplantation: prevalence and predictive factors. European Journal of Gastroenterology & Hepatology 33:3, pages 399-406.
Crossref
Crossref
Ivana Mikolasevic, Goran Hauser, Maja Mijic, Viktor Domislovic, Delfa Radic-Kristo, Zeljko Krznaric, Melanija Razov-Radas, Tajana Pavic, Marija Matasin & Tajana Filipec Kanizaj. (2021) Assessment of Steatosis and Fibrosis in Liver Transplant Recipients Using Controlled Attenuation Parameter and Liver Stiffness Measurements. Canadian Journal of Gastroenterology and Hepatology 2021, pages 1-12.
Crossref
Crossref
Maneerat Chayanupatkul, Divya B. Dasani, Kristian Sogaard & Thomas D. Schiano. (2021) The Utility of Assessing Liver Allograft Fibrosis and Steatosis Post–Liver Transplantation Using Transient Elastography With Controlled Attenuation Parameter. Transplantation Proceedings 53:1, pages 159-165.
Crossref
Crossref
Cristina Rigamonti, Carla De Benedittis & Maria Francesca Donato. 2021. Elastography of the Liver and Beyond. Elastography of the Liver and Beyond
75
89
.
Ahad Eshraghian, Saman Nikeghbalian, Alireza Shamsaeefar, Kourosh Kazemi, Mohammad Reza Fattahi & Seyed Ali Malek-Hosseini. (2020) Hepatic steatosis and liver fat contents in liver transplant recipients are associated with serum adipokines and insulin resistance. Scientific Reports 10:1.
Crossref
Crossref
. (2020)
Ueg
Week 2020 Poster Presentations
. United European Gastroenterology Journal 8:S8, pages 144-887.
Crossref
Crossref
Tae Yoo, Kwang‐Woong Lee, Nam‐Joon Yi, Suk Kyun Hong, Jeong‐Moo Lee, Hyeyoung Kim, Jieun Lim, Sooin Seo & Kyung‐Suk Suh. (2020) Impact of PNPLA3 (rs738409‐G) polymorphism on post‐transplant outcomes after liver transplantation for alcohol‐related liver disease. Clinical Transplantation 34:9.
Crossref
Crossref
Marine Dubois, Maxime Ronot, Pauline Houssel-Debry, Vanessa Brun, Michel Rayar, Magali Auger, Luc Beuzit, Bruno Turlin, Christophe Aubé & Anita Paisant. (2020) Performance of B-mode ratio and 2D shear wave elastography for the detection and quantification of hepatic steatosis and fibrosis after liver transplantation. European Journal of Gastroenterology & Hepatology 32:2, pages 222-230.
Crossref
Crossref
Guido Piai, Giovanna Valente & Luca Rinaldi. 2020. Liver Elastography. Liver Elastography
393
409
.
Adam C. Winters, Rasham Mittal & Thomas D. Schiano. (2019) A review of the use of transient elastography in the assessment of fibrosis and steatosis in the post–liver transplant patient. Clinical Transplantation 33:10.
Crossref
Crossref
Giacomo Germani, Marie Laryea, Laura Rubbia-Brandt, Hiroto Egawa, Patrizia Burra, John O'Grady & Kymberly D. Watt. (2019) Management of Recurrent and De Novo NAFLD/NASH After Liver Transplantation. Transplantation 103:1, pages 57-67.
Crossref
Crossref
Pavel Trunečka, Irena Míková, Dana Dlouhá, Jaroslav A. Hubáček, Eva Honsová, Libor Kolesár, Věra Lánská, Soňa Fraňková, Jan Šperl, Milan Jirsa & Rudolf Poledne. (2018) Donor PNPLA3 rs738409 genotype is a risk factor for graft steatosis. A post-transplant biopsy-based study. Digestive and Liver Disease 50:5, pages 490-495.
Crossref
Crossref
Andrew D. Clouston & Stefan G. Hübscher. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver
880
965
.
Lukas W. Unger, Gabriela A. Berlakovich, Michael Trauner & Thomas Reiberger. (2017) Management of portal hypertension before and after liver transplantation. Liver Transplantation 24:1, pages 112-121.
Crossref
Crossref
Thomas Ebert, Nicolas Linder, Alexander Schaudinn, Harald Busse, Joachim Berger, Ralf Lichtinghagen, Volker Keim, Johannes Wiegand & Thomas Karlas. (2017) Association of fetuin B with markers of liver fibrosis in nonalcoholic fatty liver disease. Endocrine 58:2, pages 246-252.
Crossref
Crossref
P Lancia, T Adam de Beaumais & E Jacqz-Aigrain. (2017) Pharmacogenetics of posttransplant diabetes mellitus. The Pharmacogenomics Journal 17:3, pages 209-221.
Crossref
Crossref
Stefano Gitto & Erica Villa. (2016) Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver Transplant. International Journal of Molecular Sciences 17:4, pages 490.
Crossref
Crossref
Anita Arslanow, Caroline S. Stokes, Susanne N. Weber, Frank Grünhage, Frank Lammert & Marcin Krawczyk. (2016)
The common
PNPLA3
variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP)
. Liver International 36:3, pages 418-426.
Crossref
Crossref